239 results on '"Yip-Schneider, Michele T."'
Search Results
2. Potential Health Disparities in the Early Detection and Prevention of Pancreatic Cancer
3. Magnetic resonance imaging-derived fat fraction predicts risk of malignancy in intraductal papillary mucinous neoplasm
4. Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer
5. Biomarker Risk Score Algorithm and Preoperative Stratification of Patients with Pancreatic Cystic Lesions
6. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection
7. Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts
8. Preoperative Nomogram Predicts Non-home Discharge in Patients Undergoing Pancreatoduodenectomy
9. Clinical criteria for integrated molecular pathology in intraductal papillary mucinous neoplasm: less is more
10. DNA profile components predict malignant outcomes in select cases of intraductal papillary mucinous neoplasm with negative cytology
11. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
12. Pancreatic cyst fluid glucose: rapid, inexpensive, and accurate diagnosis of mucinous pancreatic cysts
13. Circulating Leptin and Branched Chain Amino Acids—Correlation with Intraductal Papillary Mucinous Neoplasm Dysplastic Grade
14. Prostaglandin E2: A Pancreatic Fluid Biomarker of Intraductal Papillary Mucinous Neoplasm Dysplasia
15. Accurate Identification of Mucinous Pancreatic Cystic Lesions Using Small-Volume Analytes
16. Supplementary Figure S1-S9. from Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts
17. Supplementary Table S5 from Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts
18. A Quantitative Global Proteomics Approach Identifies Candidate Urinary Biomarkers That Correlate With Intraductal Papillary Mucinous Neoplasm Dysplasia
19. Pancreatic Cyst Fluid Vascular Endothelial Growth Factor A and Carcinoembryonic Antigen: A Highly Accurate Test for the Diagnosis of Serous Cystic Neoplasm
20. Pancreatic Fluid Interleukin-1β Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia
21. Amplification-Free, High-Throughput Nanoplasmonic Quantification of Circulating MicroRNAs in Unprocessed Plasma Microsamples for Earlier Pancreatic Cancer Detection
22. Intraductal Papillary Mucinous Neoplasia Originating From the Accessory (Santorini) Duct: A Rare Entity.
23. Novel Preoperative Patient-centered Surgical Wellness Program Impacts Length of Stay Following Pancreatectomy
24. Dimethylamino Parthenolide Enhances the Inhibitory Effects of Gemcitabine in Human Pancreatic Cancer Cells
25. Alcohol Activates the Hedgehog Pathway and Induces Related Procarcinogenic Processes in the Alcohol-Preferring Rat Model of Hepatocarcinogenesis
26. Pancreatic Cancer Cell Genetics and Signaling Response to Treatment Correlate with Efficacy of Gemcitabine-Based Molecular Targeting Strategies
27. PGE2 in Pancreatic Cyst Fluid Helps Differentiate IPMN from MCN and Predict IPMN Dysplasia
28. Novel expression of vascular endothelial growth factor isoforms in the pancreas and pancreatic cystic lesions
29. Targeting MEK is Effective Chemoprevention of Hepatocellular Carcinoma in TGF-α-Transgenic Mice
30. Insurance Type and Marital Status Impact Hospital Length of Stay After Pancreatoduodenectomy
31. Intraductal Papillary Mucinous Neoplasia Originating From the Accessory (Santorini) Duct: A Rare Entity
32. Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4 mutations predominantly in low-grade regions
33. Inhibition of the phosphatidylinositol 3’-kinase signaling pathway increases the responsiveness of pancreatic carcinoma cells to sulindac
34. The first synthesis of a borylated α-methylene-γ-butyrolactone
35. Alcohol Induces Liver Neoplasia in a Novel Alcohol-Preferring Rat Model
36. Preoperative Nomogram Predicts Non-home Discharge in Patients Undergoing Pancreatoduodenectomy
37. Performance of candidate urinary biomarkers for pancreatic cancer - Correlation with pancreatic cyst malignant progression?
38. Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma
39. Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4 mutations predominantly in low-grade regions.
40. Multifocal High-Grade Pancreatic Precursor Lesions: A Case Series and Management Recommendations
41. Circulating Thrombospondin-2 enhances prediction of malignant intraductal papillary mucinous neoplasm
42. Circulating Leptin and Branched Chain Amino Acids—Correlation with Intraductal Papillary Mucinous Neoplasm Dysplastic Grade
43. Abstract 3121: Characterization of immune profiling of pancreatic intraductal papillary mucinous neoplasm using multiplex immunofluorescence and image analysis approaches
44. Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4mutations predominantly in low-grade regions
45. Factors influencing the cytotoxicity of α-methylene-γ-hydroxy esters against pancreatic cancer
46. Synthetic α-(aminomethyl)-γ-butyrolactones and their anti-pancreatic cancer activities
47. Prostaglandin E2: A Pancreatic Fluid Biomarker of Intraductal Papillary Mucinous Neoplasm Dysplasia.
48. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers.
49. Cyclooxygenase-2 Expression in Hamster and Human Pancreatic Neoplasia1
50. Tailored α-methylene-γ-butyrolactones and their effects on growth suppression in pancreatic carcinoma cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.